Evidence map›Paper›PMID 29540751›Full record

ArticleCell death & disease2018

miR199a-5p inhibits hepatic insulin sensitivity via suppression of ATG14-mediated autophagy.

Bo Li, Xiangsong Wu, Hanbei Chen, Chengle Zhuang, Zhiguo Zhang, Shuangshuang Yao, Dongsheng Cai, Guang Ning, Qing Su

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Bo LiDepartment of Endocrinology, XinHua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.ORCID 0000-0003-2783-9300
Xiangsong WuDepartment of General Surgery, XinHua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Hanbei ChenDepartment of Endocrinology, XinHua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Chengle ZhuangDepartment of Gastrointestinal Surgery, Shanghai Tenth People's Hospital Affiliated with Tongji University, Shanghai, 310000, China.
Zhiguo ZhangShanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Shuangshuang YaoShanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Dongsheng CaiDepartment of Molecular Pharmacology, Diabetes Research Center, Institute of Aging, Albert Einstein College of Medicine, Bronx, New York, 10461, USA.
Guang NingShanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. guangning@medmail.com.cn.
Qing SuDepartment of Endocrinology, XinHua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China. suqing@xinhuamed.com.cn.ORCID 0000-0001-7945-1258
Shanghai Jiao Tong University · CNAlbert Einstein College of Medicine · USTongji University · CN

Funding

Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
NIDDK NIH HHS P30 DK020541
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are known to contribute to many metabolic diseases, including diabetes. In this study, we investigated the role of miR199a-5p in the regulation of hepatic insulin sensitivity. Ad-anti-miR199a-5p adenoviruses were injected into male C57BL/6J WT mice fed a high-fat diet to inhibit miR199a-5p expression before the glucose levels and insulin resistance were assessed. Similarly, Ad-miR199a-5p adenoviruses were injected into male C57BL/6J WT mice to cause the overexpression of miR199a-5p. To investigate the roles of autophagy-related protein 14 (ATG14) and miR199a-5p in the regulation of insulin sensitivity, we injected Ad-miR199a-5p with or without Ad-ATG14 viruses into WT C57BL/6J mice before performing functional assays. Moreover, we infected HepG2 cells or primary hepatocytes with Ad-anti-miR199a-5p or Ad-miR199a-5p viruses to determine the effect of miR199a-5p on insulin resistance in vitro. Finally, we explored the clinical relevance of miR199a-5p by examining the expression level of miR199a-5p in liver samples derived from diabetes patients. We first demonstrated that knocking down miR199a-5p led to decreased glucose tolerance and clearance in vivo, whereas the overexpression of miR199a-5p had the opposite effect. We further identified ATG14 as the target of miR199a-5p, and ATG14 partially rescued miR199a-5p-potentiated glucose and insulin tolerance. In addition, transmission electron microscopy data and western blot data regarding ATG14, LC3 and BECLIN1 illustrated that miR199a-5p regulates autophagy via ATG14. Knocking down miR199a-5p in primary hepatocytes and HepG2 cells suppressed the insulin-stimulated phosphorylation of insulin receptor β, glycogen synthase kinase 3β and protein kinase B, whereas the overexpression of miR199a-5p further potentiated their phosphorylation. Finally, we detected upregulated miR199a-5p levels, which were correlated with reduced ATG14 mRNA levels and downregulated autophagy in liver samples obtained from diabetes patients. Our study uncovered a novel biological role of miR199a-5p in the regulation of hepatic insulin sensitivity via ATG14-mediated autophagy.

Indexed as

AutophagyAnimalsAutophagy-Related ProteinsDiabetes Mellitus, Type 2GlucoseHepatocytesHumansInsulinLiverMaleMiceMice, Inbred C57BLMicroRNAsProto-Oncogene Proteins c-aktReceptor, InsulinVesicular Transport ProteinsAtg14 protein, mouseAutophagy-Related ProteinsGlucoseInsulinMicroRNAsMirn199 microRNA, mouseProto-Oncogene Proteins c-aktReceptor, InsulinVesicular Transport Proteins

Identifiers

PMID29540751
PMCPMC5851987
OpenAlexW2792061447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.